Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing an effective P & T Committee, Part 2.

P W Abramowitz, H N Godwin, C J Latiolais

    Hospital Formulary
    |September 7, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Individual subject meta-analysis of parameters for Giardia duodenalis shedding in animal experimental models.

    BioMed research international·2014
    Same author

    Zoonotic fecal pathogens and antimicrobial resistance in county fair animals.

    Comparative immunology, microbiology and infectious diseases·2012
    Same author

    Otitis media associated with Cryptosporidium baileyi in a Saker falcon (Falco cherrug).

    Journal of comparative pathology·2012
    Same author

    Individual subject meta-analysis of parameters for Cryptosporidium parvum shedding and diarrhoea in animal experimental models.

    Epidemiology and infection·2012
    Same author

    Subacute bacterial endocarditis due to B. tularense, treated by streptomycin.

    The Illinois medical journal·2010
    Same author

    The effect upon pulse rate of various cadences in the step-up test.

    Research quarterly·2010

    The Pharmacy and Therapeutics (P&T) Committee faces evolving healthcare challenges, requiring adaptation in drug cost-effectiveness and formulary management. This includes defining roles for physicians, pharmacists, and pharmacy directors in standardizing therapy and dosing policies.

    Area of Science:

    • Health Policy
    • Pharmacy Administration
    • Pharmacoeconomics

    Background:

    • Healthcare reforms necessitate adjustments in hospital pharmacy and therapeutics committee functions.
    • Increasing focus on cost-effective drug therapy presents new challenges for P&T Committees.
    • The evolving landscape requires P&T Committees to address formulary management and non-formulary agent use.

    Purpose of the Study:

    • To analyze the impact of healthcare changes on P&T Committee operations.
    • To provide guidance on managing cost-effective drug therapy and formulary decisions.
    • To clarify the roles of various stakeholders within the P&T Committee structure.

    Main Methods:

    • Review of current healthcare trends and their influence on P&T Committee responsibilities.

    Related Experiment Videos

  • Discussion of formulary admission criteria and the use of non-formulary medications.
  • Identification of interdisciplinary roles, including physicians, pharmacists, and pharmacy directors.

    • Main Results:

    • P&T Committees must proactively address issues of cost-effectiveness in drug selection.
    • Clear definition of roles for physicians and pharmacists is crucial for effective committee function.
    • Standardization of therapy and drug-dosing policies emerged as key areas for P&T Committee focus.

    Conclusions:

    • P&T Committees require enhanced preparedness to navigate new healthcare challenges, particularly regarding drug costs.
    • Effective collaboration and defined roles among healthcare professionals are essential for optimal P&T Committee performance.
    • Implementing standardized therapeutic and dosing guidelines is vital for efficient and cost-effective medication management.